Financials Kwong Lung Enterprise Co., Ltd.

Equities

8916

TW0008916008

Apparel & Accessories

End-of-day quote Taipei Exchange 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
60 TWD -0.33% Intraday chart for Kwong Lung Enterprise Co., Ltd. +1.35% +5.45%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 6,674 5,255 5,323 7,285 8,580 9,007
Enterprise Value (EV) 1 6,674 5,255 5,323 7,285 8,580 9,007
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue 0.63 x 0.62 x 0.66 x 0.71 x 1.11 x 1.08 x
EV / Revenue 0.63 x 0.62 x 0.66 x 0.71 x 1.11 x 1.08 x
EV / EBITDA - - - - - -
EV / FCF 13,008,736 x - - 5,532,895 x - -
FCF Yield 0% - - 0% - -
Price to Book 1.17 x 1.22 x - 1.33 x - 1.61 x
Nbr of stocks (in thousands) 148,310 131,052 131,274 139,033 150,793 150,114
Reference price 2 45.00 40.10 40.55 52.40 56.90 60.00
Announcement Date 3/29/20 3/17/21 3/29/22 3/15/23 3/15/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 10,594 8,499 8,061 10,304 7,708 8,313
EBITDA - - - - - -
EBIT 1 595.5 380.4 187.9 953.7 597.2 680
Operating Margin 5.62% 4.48% 2.33% 9.26% 7.75% 8.18%
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Free Cash Flow 513 - - 1,317 - -
FCF margin 4.84% - - 12.78% - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/20 3/17/21 3/29/22 3/15/23 3/15/24 -
1TWD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 1,796 2,179 - 3,210 2,151 1,746 2,468 2,185 1,309 1,422 2,443 2,522 1,926
EBITDA - - - - - - - - - - - - -
EBIT 1 33.3 -8.578 - 350.7 172.8 122.3 258.7 184.1 32.12 82 269 301 29
Operating Margin 1.85% -0.39% - 10.92% 8.03% 7.01% 10.48% 8.42% 2.45% 5.77% 11.01% 11.93% 1.51%
Earnings before Tax (EBT) - - - - - - - - - - - - -
Net income - - 439.8 - - - - - - - - - -
Net margin - - - - - - - - - - - - -
EPS - - 2.920 - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 11/11/21 3/29/22 8/10/22 11/10/22 3/15/23 5/11/23 8/10/23 11/9/23 3/15/24 - - - -
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 513 - - 1,317 - -
ROE (net income / shareholders' equity) 10.7% - - 17.5% - -
ROA (Net income/ Total Assets) 6.68% - - 10.9% - -
Assets - - - - - -
Book Value Per Share 1 38.60 32.80 - 39.50 - 37.20
Cash Flow per Share - - - - - -
Capex 136 - - 276 - -
Capex / Sales 1.28% - - 2.68% - -
Announcement Date 3/29/20 3/17/21 3/29/22 3/15/23 3/15/24 -
1TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
60 TWD
Average target price
65.55 TWD
Spread / Average Target
+9.25%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 8916 Stock
  4. Financials Kwong Lung Enterprise Co., Ltd.